home / stock / bbln / bbln news


BBLN News and Press, Babylon Holdings Limited Class A From 04/25/22

Stock Information

Company Name: Babylon Holdings Limited Class A
Stock Symbol: BBLN
Market: NYSE

Menu

BBLN BBLN Quote BBLN Short BBLN News BBLN Articles BBLN Message Board
Get BBLN Alerts

News, Short Squeeze, Breakout and More Instantly...

BBLN - Babylon Holdings Limited Reiterates Q1 Guidance and 12 May Earnings Call

Babylon Holdings Limited (NYSE:BBLN) (“Babylon”) notes the movement in its share price on April 22, 2022, with over 45x the average daily trading volume seen since its NYSE listing on October 22, 2021, concurrent with the expiry of Babylon’s 6-month lock-up of appro...

BBLN - Teladoc, 1Life among health tech stocks exposed to recession - Citi

Citi Investment Research has grouped telehealth provider, Teladoc Health (NYSE:TDOC) and membership-based primary care platform 1Life Healthcare (ONEM) among health tech stocks highly exposed to the risk of a recession. This month, the economists polled by The Wall Street Journal&#x...

BBLN - PLSE, EVLO and REDU among mid-day movers

Gainers: Vallon Pharmaceuticals (VLON) +80%. Blueknight Energy Partners (BKEP) +38%. Moving iMage Technologies (MITQ) +37%. RISE Education Cayman (REDU) +15%. Sky Harbour Group (SKYH) +14%. GWG Holdings (GWGH) +14%. Evelo Biosciences (EVLO) +13%. Chindata Group Holdings (CD) +13%. Shattuck La...

BBLN - Vallon, Shattuck Labs top healthcare gainers; Babylon, SCYNEXIS lead losers' pack

Gainers: Vallon Pharmaceuticals (VLON) +84%. Shattuck Labs (STTK) +12%. Establishment Labs (ESTA) +11%. INVO Bioscience (INVO) +5%. Novan (NOVN) +5%. Losers: Babylon Holdings (BBLN) -41%. SCYNEXIS (SCYX) -25%. Clarus Therapeutics (CRXT) -16%. HCA H...

BBLN - Babylon Announces First Quarter 2022 Financial Results Conference Call

Babylon (NYSE: BBLN) (“Babylon” or the “Company”) will host a conference call on Thursday, May 12, 2022, at 8:00 AM Eastern Time to review the Company’s first quarter 2022 financial results. A press release announcing the first quarter results will...

BBLN - Babylon Announces Filing and Availability of Annual Report on Form 20-F

Babylon Holdings Limited (NYSE:BBLN) (“Babylon” or “the Company”), one of the world’s fastest growing digital healthcare companies, today announced that its Annual Report on Form 20-F for the fiscal year ended December 31, 2021 has been filed with the ...

BBLN - Babylon's Integration With Higi Accelerates Momentum With Its AI Technology Now Available to Thousands of Americans to Support Proactive Self Care

Babylon (NYSE: BBLN) today announced the integration of its AI-powered Symptom Checker technology into Higi ’s mobile application, opening a new channel for proactive self-care health engagement for Higi’s thousands of U.S. app users. The integration follows Baby...

BBLN - Clearside, Cellectis top healthcare gainers; Orphazyme, Aesthetic lead losers' pack

Gainers: Clearside Biomedical CLSD +38%. Cellectis (NASDAQ:CLLS) +13%. NeuroPace (NASDAQ:NPCE) +12%. 4D pharma LBPS +11%. LifeStance Health (NASDAQ:LFST) +8%. Losers: Orphazyme ORPH -37%. Aesthetic Medical International (NASDAQ:AIH) -19%. Suns...

BBLN - Babylon Holdings' (BBLN) CEO Ali Parsadoust on Q4 2021 Results - Earnings Call Transcript

Babylon Holdings Ltd (BBLN) Q4 2021 Earnings Conference Call March 10, 2022 8:00 AM ET Company Participants Ali Parsadoust – Founder and Chief Executive Officer Charlie Steel – Chief Financial Officer Conference Call Participants David Larsen – BTIG Glen Santangelo ȁ...

BBLN - Babylon Holdings GAAP EPS of -$0.65, revenue of $119.69M; issues FY22 guidance

Babylon Holdings press release (NYSE:BBLN): Q4 GAAP EPS of -$0.65. Revenue of $119.69M (+192.2% Y/Y). Guidance for 2022 revenue to grow again almost another three times to $900 million to $1 billion, a 3x increase over 2021 revenue, with the incremental increase from December 2021 run rate. T...

Previous 10 Next 10